A citation-based method for searching scientific literature

Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants, Rein Willemze, Martijn H Breuning, Nelleke A Gruis. Clin Cancer Res 2008
Times Cited: 118







List of co-cited articles
928 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
279
35


Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
295
31

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Alison P Klein, Kieran A Brune, Gloria M Petersen, Michael Goggins, Anne C Tersmette, G Johan A Offerhaus, Constance Griffin, John L Cameron, Charles J Yeo, Scott Kern,[...]. Cancer Res 2004
413
30

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
487
27

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
448
26

Very high risk of cancer in familial Peutz-Jeghers syndrome.
F M Giardiello, J D Brensinger, A C Tersmette, S N Goodman, G M Petersen, S V Booker, M Cruz-Correa, J A Offerhaus. Gastroenterology 2000
807
25

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.
A B Lowenfels, P Maisonneuve, E P DiMagno, Y Elitsur, L K Gates, J Perrault, D C Whitcomb. J Natl Cancer Inst 1997
671
25

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
259
25

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
545
23

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
337
23


Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
277
22

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
249
20

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Hans F A Vasen, Martin Wasser, Anneke van Mil, Rob A Tollenaar, Marja Konstantinovski, Nelleke A Gruis, Wilma Bergman, Frederik J Hes, Daniel W Hommes, G Johan A Offerhaus,[...]. Gastroenterology 2011
111
19

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Marcia Irene Canto, Ralph H Hruban, Elliot K Fishman, Ihab R Kamel, Richard Schulick, Zhe Zhang, Mark Topazian, Naoki Takahashi, Joel Fletcher, Gloria Petersen,[...]. Gastroenterology 2012
403
19

ATM mutations in patients with hereditary pancreatic cancer.
Nicholas J Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M Petersen, Melissa L Bondy, Steven Gallinger, Ann G Schwartz, Sapna Syngal, Michele L Cote,[...]. Cancer Discov 2012
309
19

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
79
22

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.
Ralph Schneider, Emily P Slater, Mercede Sina, Nils Habbe, Volker Fendrich, Elvira Matthäi, Peter Langer, Detlef K Bartsch. Fam Cancer 2011
101
18

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
744
17

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.
F M Giardiello, G J Offerhaus, D H Lee, A J Krush, A C Tersmette, S V Booker, N C Kelley, S R Hamilton. Gut 1993
243
17

PALB2 mutations in European familial pancreatic cancer families.
E P Slater, P Langer, E Niemczyk, K Strauch, J Butler, N Habbe, J P Neoptolemos, W Greenhalf, D K Bartsch. Clin Genet 2010
168
16

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Hans Vasen, Isaura Ibrahim, Carmen Guillen Ponce, Emily P Slater, Elvira Matthäi, Alfredo Carrato, Julie Earl, Kristin Robbers, Anneke M van Mil, Thomas Potjer,[...]. J Clin Oncol 2016
183
16

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Elizabeth C Verna, Caroline Hwang, Peter D Stevens, Heidrun Rotterdam, Stavros N Stavropoulos, Carolyn D Sy, Martin A Prince, Wendy K Chung, Robert L Fine, John A Chabot,[...]. Clin Cancer Res 2010
164
15

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Kathleen M Murphy, Kieran A Brune, Constance Griffin, Jennifer E Sollenberger, Gloria M Petersen, Ravi Bansal, Ralph H Hruban, Scott E Kern. Cancer Res 2002
316
15

BRCA2 germline mutations in familial pancreatic carcinoma.
Stephan A Hahn, Bill Greenhalf, Ian Ellis, Mercedes Sina-Frey, Harald Rieder, Birgit Korte, Berthold Gerdes, Ralf Kress, Andreas Ziegler, John A Raeburn,[...]. J Natl Cancer Inst 2003
331
15

High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations.
M G F van Lier, A Wagner, E M H Mathus-Vliegen, E J Kuipers, E W Steyerberg, M E van Leerdam. Am J Gastroenterol 2010
274
15

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
156
15

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
J W Poley, I Kluijt, D J Gouma, F Harinck, A Wagner, C Aalfs, C H J van Eijck, A Cats, E J Kuipers, Y Nio,[...]. Am J Gastroenterol 2009
179
14

Importance of age of onset in pancreatic cancer kindreds.
Kieran A Brune, Bryan Lau, Emily Palmisano, Marcia Canto, Michael G Goggins, Ralph H Hruban, Alison P Klein. J Natl Cancer Inst 2010
123
14

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
Marcia Irene Canto, Michael Goggins, Charles J Yeo, Constance Griffin, Jennifer E Axilbund, Kieran Brune, Syed Z Ali, Sanjay Jagannath, Gloria M Petersen, Elliot K Fishman,[...]. Clin Gastroenterol Hepatol 2004
326
14

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
Marcia Irene Canto, Michael Goggins, Ralph H Hruban, Gloria M Petersen, Francis M Giardiello, Charles Yeo, Elliott K Fishman, Kieran Brune, Jennifer Axilbund, Constance Griffin,[...]. Clin Gastroenterol Hepatol 2006
367
14

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
P Langer, P H Kann, V Fendrich, N Habbe, M Schneider, M Sina, E P Slater, J T Heverhagen, T M Gress, M Rothmund,[...]. Gut 2009
166
13

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
326
13

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
16

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
N A Gruis, P A van der Velden, L A Sandkuijl, D E Prins, J Weaver-Feldhaus, A Kamb, W Bergman, R R Frants. Nat Genet 1995
276
13

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010
182
13

Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
Bhramar Mukherjee, John Oliver Delancey, Leon Raskin, Jessica Everett, Joanne Jeter, Colin B Begg, Irene Orlow, Marianne Berwick, Bruce K Armstrong, Anne Kricker,[...]. J Natl Cancer Inst 2012
32
40

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
50
26

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
13

Update on familial pancreatic cancer.
Ralph H Hruban, Marcia I Canto, Michael Goggins, Richard Schulick, Alison P Klein. Adv Surg 2010
148
12

Advances in counselling and surveillance of patients at risk for pancreatic cancer.
Randall E Brand, Markus M Lerch, Wendy S Rubinstein, John P Neoptolemos, David C Whitcomb, Ralph H Hruban, Teresa A Brentnall, Henry T Lynch, Marcia I Canto. Gut 2007
213
12

Feasibility and yield of screening in relatives from familial pancreatic cancer families.
Emmy Ludwig, Sara H Olson, Sharon Bayuga, Jennifer Simon, Mark A Schattner, Hans Gerdes, Peter J Allen, William R Jarnagin, Robert C Kurtz. Am J Gastroenterol 2011
118
12

Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection.
Sara Raimondi, Albert B Lowenfels, Antonio M Morselli-Labate, Patrick Maisonneuve, Raffaele Pezzilli. Best Pract Res Clin Gastroenterol 2010
355
12

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. J Natl Cancer Inst 2005
144
12

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.
J Iqbal, A Ragone, J Lubinski, H T Lynch, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen, S L Neuhausen,[...]. Br J Cancer 2012
157
12

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia.
P Ghiorzo, P Ciotti, M Mantelli, A Heouaine, P Queirolo, M L Rainero, C Ferrari, P L Santi, R De Marchi, A Farris,[...]. Int J Cancer 1999
68
16

Familial pancreatic cancer.
Chanjuan Shi, Ralph H Hruban, Alison P Klein. Arch Pathol Lab Med 2009
118
11

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
11

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian,[...]. J Med Genet 2012
48
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.